GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PharmX Technologies Ltd (ASX:PHX) » Definitions » Revenue per Share

PharmX Technologies (ASX:PHX) Revenue per Share : A$0.01 (TTM As of Dec. 2023)


View and export this data going back to 1973. Start your Free Trial

What is PharmX Technologies Revenue per Share?

PharmX Technologies's revenue per share for the six months ended in Dec. 2023 was A$0.01. PharmX Technologies's revenue per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.01.

Warning Sign:

PharmX Technologies Ltd revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue Per Share Growth Rate of PharmX Technologies was -75.00% per year. During the past 3 years, the average Revenue Per Share Growth Rate was -26.30% per year. During the past 5 years, the average Revenue Per Share Growth Rate was -22.80% per year. During the past 10 years, the average Revenue Per Share Growth Rate was -16.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for PharmX Technologies's Revenue per Share or its related term are showing as below:

ASX:PHX' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -35   Med: -15.3   Max: 15
Current: -26.3

During the past 13 years, PharmX Technologies's highest 3-Year average Revenue Per Share Growth Rate was 15.00% per year. The lowest was -35.00% per year. And the median was -15.30% per year.

ASX:PHX's 3-Year Revenue Growth Rate is ranked worse than
93.43% of 578 companies
in the Healthcare Providers & Services industry
Industry Median: 9.75 vs ASX:PHX: -26.30

PharmX Technologies Revenue per Share Historical Data

The historical data trend for PharmX Technologies's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmX Technologies Revenue per Share Chart

PharmX Technologies Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.03 0.02 0.02 0.01

PharmX Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 - 0.01

Competitive Comparison of PharmX Technologies's Revenue per Share

For the Health Information Services subindustry, PharmX Technologies's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmX Technologies's PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PharmX Technologies's PS Ratio distribution charts can be found below:

* The bar in red indicates where PharmX Technologies's PS Ratio falls into.



PharmX Technologies Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

PharmX Technologies's Revenue Per Share for the fiscal year that ended in Jun. 2023 is calculated as

Revenue Per Share (A: Jun. 2023 )=Revenue (A: Jun. 2023 )/Shares Outstanding (Diluted Average) (A: Jun. 2023 )
=6.018/597.169
=0.01

PharmX Technologies's Revenue Per Share for the quarter that ended in Dec. 2023 is calculated as

Revenue Per Share (Q: Dec. 2023 )=Revenue (Q: Dec. 2023 )/Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
=3.142/597.853
=0.01

Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmX Technologies  (ASX:PHX) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


PharmX Technologies Revenue per Share Related Terms

Thank you for viewing the detailed overview of PharmX Technologies's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmX Technologies (ASX:PHX) Business Description

Traded in Other Exchanges
N/A
Address
17 Castlereagh Street, Level 11, Sydney, NSW, AUS, 2000
PharmX Technologies Ltd Formerly Corum Group Ltd is an Australia-based software and technology company. The company has a single segment which is Health Services. In Health services, the company develops and distributes business software for the pharmacy industry with particular emphasis on point-of-sale and pharmaceutical dispensing software, support services, and associated computer hardware. It derives a majority of its revenue from the Health services business. the company discontinued the e-commerce business in 2022.